Jean-Charles Nault(@NaultJc) 's Twitter Profileg
Jean-Charles Nault

@NaultJc

Soignant dans le service d’hépatologie Hôpital Avicenne 93, Centre de Recherche des Cordeliers

ID:1024970975560040448

linkhttps://foiecancer93.fr calendar_today02-08-2018 10:51:38

2,1K Tweets

797 Followers

325 Following

Eric Vibert(@Eric_Vibert) 's Twitter Profile Photo

Proud of my team Centre Hépato-Biliaire, Hôpital Paul Brousse AP-HP Université Paris-Saclay, is the only true RCT in Liver Transplant. but ⚠️ it must not be Box Pandora opening. LT better than chemo for but after a drastic selection ! Agence de la biomédecine ILTS Gustave Roussy 👇
meetings.asco.org/abstracts-pres…

account_circle
Ezequiel Mauro(@ezemauro_ok) 's Twitter Profile Photo

Latest editorial in Liver International: RFA as an effective and safe treatment for iCCA, especially in cirrhosis. Cutoff: 2 cm results in⬇️recurrence and⬆️survival, aiding in early-stage definition.Alejandro Forner BCLC GROUP Ángeles García Criado
onlinelibrary.wiley.com/doi/abs/10.111…
onlinelibrary.wiley.com/doi/10.1111/li…

account_circle
NEJM AI(@NEJM_AI) 's Twitter Profile Photo

Case Study: GPT-4 for Information Retrieval and Comparison of Medical Oncology Guidelines nejm.ai/3WSVQ19

Review Article: Clinical Text Datasets for Medical Artificial Intelligence and Large Language Models — A Systematic Review nejm.ai/3wNGMXM

account_circle
nature(@Nature) 's Twitter Profile Photo

Nature research paper: A deep catalogue of protein-coding variation in 983,578 individuals go.nature.com/4bNoQeU

account_circle
Clara Zucman-Rossi(@ClaraZR) 's Twitter Profile Photo

Henriette Pinchon a sauvé mon grand-père Jean Zucman et sa sœur Denis Zucman en les cachant (comme 40 autres enfants) à Boussoles.
justes.msh.uca.fr/pichon-henriet…

Jessica Zucman-Rossi

account_circle
Jesus Bañales(@JesusMBanales) 's Twitter Profile Photo

1/🚀JHEP Journal Club🚀

😲Deep molecular profiling of primary sclerosing cholangitis (PSC) livers at cell level‼️

🍀PSC👉chronic cholestatic & immune-mediated liver/biliary disease
🤔Etiology elusive...

Tallulah S. Andrew & cols achieved a milestone 👇👇👇

1/🚀JHEP Journal Club🚀 😲Deep molecular profiling of primary sclerosing cholangitis (PSC) livers at cell level‼️ 🍀PSC👉chronic cholestatic & immune-mediated liver/biliary disease 🤔Etiology elusive... Tallulah S. Andrew & cols achieved a milestone 👇👇👇 #livertwitter
account_circle
Science Magazine(@ScienceMagazine) 's Twitter Profile Photo

Hibernating brown bears rarely suffer from blood clots despite 6 months of immobilization.

A 2023 Science study revealed a factor that appears to protect the animals against this immobility-associated thrombosis. scim.ag/6Wn

Hibernating brown bears rarely suffer from blood clots despite 6 months of immobilization. A 2023 Science study revealed a factor that appears to protect the animals against this immobility-associated thrombosis. scim.ag/6Wn #ScienceMagArchives
account_circle
Jordi Bruix(@bruixj) 's Twitter Profile Photo

The history of HCC therapy. Proudly written to honor those that have been key players to move the field forward. Looking back allows to step into the future without outdated issues and some major problems already solved.
pubmed.ncbi.nlm.nih.gov/38707239/ Hospital Clínic IDIBAPS CIBERehd

account_circle
Denis Wirtz(@deniswirtz) 's Twitter Profile Photo

Why 3D omic and not simply 2D omic?

Our recent paper determines the number of spatially distinct precursor lesions, their morphology and mutational profile.

None of this can be done in 2D. And only CODA can do it. nature.com/articles/s4158…

Also: biorxiv.org/content/10.110…

Why 3D omic and not simply 2D omic? Our recent paper determines the number of spatially distinct precursor lesions, their morphology and mutational profile. None of this can be done in 2D. And only CODA can do it. nature.com/articles/s4158… Also: biorxiv.org/content/10.110…
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

Multicentre phs II trial of cabozantinib in HCC after immune checkpoint inhibitors
Journal of Hepatology
doi.org/10.1016/j.jhep…
🧐Efficacy of Cabozantinib in 2nd line after ICI, but disappointing data in 3rd line
ESMO - Eur. Oncology Milca Malary EASL Education

Multicentre phs II trial of cabozantinib in HCC after immune checkpoint inhibitors @JHepatology doi.org/10.1016/j.jhep… 🧐Efficacy of Cabozantinib in 2nd line after ICI, but disappointing data in 3rd line @myESMO @ilca @EASLedu #livertwitter
account_circle
Jesus Bañales(@JesusMBanales) 's Twitter Profile Photo

1/ 🚀 JHEP Journal Club🚀

🤔Emerging Epigenetic Therapies for Hepatoblastoma (HB): A New Era?

HB👉most common liver cancer in👶
🫤 1% of all pediatric malignancies

Treatment-refractory HB have limited options with survival rates of less than 50%... 👇👇
@livertwitter

1/ 🚀 JHEP Journal Club🚀 🤔Emerging Epigenetic Therapies for Hepatoblastoma (HB): A New Era? HB👉most common liver cancer in👶 🫤 1% of all pediatric malignancies Treatment-refractory HB have limited options with survival rates of less than 50%... 👇👇 @livertwitter
account_circle
Virginia(@VirginiaHdezGea) 's Twitter Profile Photo

Elastography is an essential tool in hepatology! Still didn’t try spleen probe? M, XL?? Do not miss this opportunity 👇🏼📢special call for nurses📢 join the SLC Laura Turco Núria Fabrellas EASLnews 👇🏼👇🏼

account_circle
Jean-Charles Nault(@NaultJc) 's Twitter Profile Photo

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy | Nature nature.com/articles/s4158…

account_circle